May 17, 2026
Trip report or trauma breakthrough?
Scientists believe ibogaine can help veterans overcome PTSD
Miracle trip or risky hype? Commenters are split as veterans chase PTSD relief
TLDR: A small study suggests ibogaine, a powerful psychedelic, could help veterans with PTSD after one supervised session, but scientists still don’t know why it works. Commenters are fighting over the risks, the focus on veterans, and fears that vulnerable people could get sucked into dangerous pseudo-healing scenes.
The science headline is dramatic enough: a powerful psychedelic called ibogaine may help veterans with post-traumatic stress disorder, after a small trial found major improvements in anxiety, depression, and daily functioning after just one guided session in Mexico. But in the comments, readers were far less interested in the glowing before-and-after arc and far more interested in asking, hold on, why this drug, why veterans, and who exactly gets protected here?
That’s where the real fireworks started. One camp saw hope in the story of former Navy medic Elias Kfoury, who described an intense, emotional trip through old memories after years of pain and failed treatments. Another camp instantly hit the brakes: ibogaine is banned in many places because it can be dangerous, especially for the heart, and commenters warned that desperate people can be lured into sketchy “wellness” scenes dressed up as healing. One reader basically rewrote the headline on the spot to remind everyone: this is still a banned hallucinogen.
Then came the debate over who this story centers. Why only veterans, one commenter asked, when many more women live with trauma after assault? Others tossed in alternative-treatment hot takes, from “why not salvia?” to the surprise dark-horse candidate, electroshock therapy, with one commenter bluntly suggesting memory loss might actually help here. So yes, the article is about a possible PTSD breakthrough — but the comments turned it into a full-on brawl over risk, access, media framing, and whether this is healing, hype, or both.
Key Points
- •The article examines ibogaine as a potential treatment for PTSD and other conditions, while emphasizing that scientists still do not know how it works.
- •Former US Navy medic Elias Kfoury underwent ibogaine treatment in Tijuana, Mexico after other therapies and medications failed to relieve his PTSD and related symptoms.
- •A study involved 30 US special forces veterans whose treatment in Mexico was monitored by Stanford University researchers.
- •Participants received ibogaine in supervised sessions, with doses up to 14 mg/kg over three hours, and psychedelic effects that could last up to 72 hours.
- •Researchers reported post-treatment improvements in PTSD, depression and anxiety, and a follow-up study linked more intense immersive experiences with greater PTSD symptom reduction.